Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,807,289
+$2,662,800 QoQ
Shares Held
139,458
+991.1% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#58
of 182 holders
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 91.03672790374164.ToString("F0")%
Shared 0.ToString("F0")%
None 8.963272096258372.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. KALV ranks #61 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
483,971 | $24,585,726 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
61,760 | $20,434,531 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
277,114 | $17,375,047 | |
| 4 | EXEL |
Exelixis, Inc.
|
390,818 | $16,762,184 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
594,850 | $16,661,748 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
213,645 | $16,042,603 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
390,951 | $15,528,573 | |
| 8 | ASND |
Ascendis Pharma A/S
|
65,517 | $14,985,703 |
All Filings in KALV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,807,289 | 139,458 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $144,489 | 12,781 | Shares | Sole | 2025-08-12 | |
| 2024-03-31 | $657,565 | 55,444 | Shares | Sole | 2024-05-14 | |
| 2022-06-30 | $384,232 | 39,048 | Shares | Sole | 2022-08-11 | |
| 2021-12-31 | $226,643 | 17,131 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $333,958 | 19,138 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $159,344 | 13,169 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||